Resources

Paling, F. P., Andrews, L. M., Valk, G. D., & Blom, H. J. (2012). Life-threatening complications of ibogaine: three case reports. The Netherlands journal of medicine, 70(9), 422–424. https://pubmed.ncbi.nlm.nih.gov/23123541/

1. Schenberg, E. E., de Castro Comis, M. A., Chaves, B. R., & da Silveira, D. X. (2014). Treating drug dependence with the aid of ibogaine: a retrospective study. Journal of psychopharmacology (Oxford, England), 28(11), 993–1000. https://pubmed.ncbi.nlm.nih.gov/25271214/
2. Summary of Federal and State Drug Laws, https://spu.edu/~/media/university-leadership/student-life/Summary%20of%20Federal%20and%20State%20Drug%20Laws%20as%20of%205-6-16.ashx
3. Aćimović, T., Atanasijević, T., Denić, K., Lukić, V., Popović, V., & Bogdanović, M. (2021). Death due to consumption of ibogaine: case report. Forensic science, medicine, and pathology, 17(1), 126–129. https://pubmed.ncbi.nlm.nih.gov/33433774/
4. Asua I. (2013). The growing menace of ibogaine toxicity. British journal of anesthesia, 111(6), 1029–1030. https://pubmed.ncbi.nlm.nih.gov/24233315/
5. Corkery J. M. (2018). Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers. Progress in brain research, 242, 217–257. https://pubmed.ncbi.nlm.nih.gov/30471681/
6. Noller, G. E., Frampton, C. M., & Yazar-Klosinski, B. (2018). Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study. The American journal of drug and alcohol abuse, 44(1), 37–46. https://pubmed.ncbi.nlm.nih.gov/28402682/